文献速递结核与非结核分枝杆菌艾滋病与性传播感染

注射用避孕药醋酸甲羟孕酮通过糖皮质激素受体削弱结核分枝杆菌特异性宿主免疫

The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.
PubMed 文献 · J Infect Dis · 2019-01-01

研究在南非开普敦招募未感染HIV且未使用避孕药的女性,评估醋酸甲羟孕酮(MPA)、炔诺酮醋酸酯(NET-A)和地塞米松对巨噬细胞控制结核分枝杆菌的影响。结果显示MPA和地塞米松(而非NET-A)在生理浓度下剂量依赖性削弱结核控制,且该效应可被糖皮质激素受体拮抗剂米非司酮逆转。MPA还上调调节性T细胞并抑制CD4+和CD8+保护性免疫通路。

要点

  • MPA而非NET-A在体外削弱巨噬细胞对结核分枝杆菌的控制
  • MPA通过糖皮质激素受体上调调节性T细胞并抑制Th1和颗粒酶/穿孔素通路
  • 米非司酮可逆转MPA的免疫抑制效应

核心结论

  • MPA而非NET-A在体外削弱分枝杆菌控制,并通过糖皮质激素受体下调保护性CD4+和CD8+相关免疫通路。

研究设计与样本

  • 研究招募未感染HIV且未使用避孕药的女性,来自南非开普敦,评估MPA、NET-A和地塞米松对单核细胞衍生巨噬细胞中结核分枝杆菌控制的影响。

主要发现

  • MPA(P < .005)和地塞米松(P < .01)而非NET-A在生理相关浓度下剂量依赖性显著削弱与PPD驱动的效应细胞共培养的感染巨噬细胞对结核分枝杆菌的控制。
  • 米非司酮(RU486)拮抗糖皮质激素受体可消除MPA对结核控制的削弱。
  • 在PPD刺激的外周血单核细胞中,MPA和地塞米松而非NET-A上调调节性T细胞(中位数[四分位距] 5.3% [3.1%-18.2%];P < .05),降低CD4+ T细胞干扰素-γ(21% [0.5%-28%];P < .05)和颗粒酶B产生(12.6% [7%-13.5%];P < .05),并降低CD8+穿孔素活性(2.2% [0.1%-7%];P < .05)。
  • RU486逆转了调节性T细胞的上调和对Th1及颗粒酶/穿孔素相关通路的抑制效应。

临床怎么用

  • 在结核病流行国家选择和使用注射用避孕药时,应考虑MPA对结核特异性免疫的潜在削弱作用。

局限性

  • 研究为体外实验,结论需在临床人群中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effects of the widely used progestin-only injectable contraceptives, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A), on host susceptibility to Mycobacterium tuberculosis (Mtb) are unknown. METHODS: We recruited human immunodeficiency virus-uninfected females, not taking any contraceptives, from Cape Town, South Africa, to evaluate the effect of MPA, NET-A, and dexamethasone on Mtb containment in monocyte-derived macrophages co-incubated with purified protein derivative (PPD)-driven peripheral blood-derived effector cells. RESULTS: MPA (P < .005) and dexamethasone (P < .01), but not NET-A, significantly attenuated Mtb containment in Mtb-infected macrophages co-cultured with PPD-driven effector cells at physiologically relevant concentrations and in a dose-dependent manner. Antagonizing the glucocorticoid receptor with mifepristone (RU486) abrogated the reduction in Mtb containment. In PPD-stimulated peripheral blood mononuclear cells, MPA and dexamethasone, but not NET-A, upregulated (median [interquartile range]) regulatory T cells (5.3% [3.1%-18.2%]; P < .05), reduced CD4+ T-cell interferon-γ (21% [0.5%-28%]; P < .05) and granzyme B production (12.6% [7%-13.5%]; P < .05), and reduced CD8+ perforin activity (2.2% [0.1%-7%]; P < .05). RU486 reversed regulatory T-cell up-regulation and the inhibitory effect on Th1 and granzyme/perforin-related pathways. CONCLUSIONS: MPA, but not NET-A, subverts mycobacterial containment in vitro and downregulates pathways associated with protective CD8+- and CD4+-related host immunity via the glucocorticoid receptor. These data potentially inform the selection and use of injectable contraceptives in tuberculosis-endemic countries.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tomasicchio M, Davids M, Pooran A, et al. The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor. J Infect Dis. 2019. PMID: 30452655. doi:10.1093/infdis/jiy657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。